|
1.
|
Goldstraw P, Crowley J, Chansky K, et al:
International Association for the Study of Lung Cancer
International Staging Committee and Participating Institutions. The
IASCL Lung Cancer Staging Project: proposals for the revision of
the TNM stage groupings in the forthcoming (seventh) edition of the
TNM classification of malignant tumours. J Thorac Oncol. 2:706–714.
2007.
|
|
2.
|
Auperin A, Le Pechoux C, Pignon JP, et al:
Concomitant radio-chemotherapy based on platin compounds in
patients with locally advanced non-small cell lung cancer (NSCLC):
a meta-analysis of individual data from 1764 patients. Ann Oncol.
17:473–483. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Auperin A, Le Pechoux C, Rolland E, et al:
Meta-analysis of concomitant versus sequential radiochemotherapy in
locally advanced non-small-cell lung cancer. J Clin Oncol.
28:2181–2190. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Vokes EE, Herndon JE II and Crawford J:
Randomized phase II study of cisplatin with gemcitabine or
paclitaxel or vinorelbine as induction chemotherapy followed by
concomitant chemoradiotherapy for stage IIIB non-small-cell lung
cancer: cancer and leukemia group B study 9431. J Clin Oncol.
20:4191–4198. 2002. View Article : Google Scholar
|
|
5.
|
Go RS and Adjei AA: Review of the
comparative pharmacology and clinical activity of cisplatin and
carboplatin. J Clin Oncol. 17:409–422. 1999.PubMed/NCBI
|
|
6.
|
Yamamoto N, Nakagawa K, Nishimura Y, et
al: Phase III study comparing second-and third-generation regimens
with concurrent thoracic radiotherapy in patients with unresectable
stage III non-small-cell lung cancer: West Japan Thoracic Oncology
Group WJTOG0105. J Clin Oncol. 28:3739–3745. 2010. View Article : Google Scholar
|
|
7.
|
Hotta K, Matsuo K, Ueoka H, Kiura K,
Tabata M and Tanimoto M: Meta-analysis of randomized clinical
trials comparing cisplatin to carboplatin in patients with advanced
non-small-cell lung cancer. J Clin Oncol. 22:3852–3859. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Ardizzoni A, Boni L, Tiseo M, et al:
Cisplatin-versus carboplatin-based chemotherapy in first-line
treatment of advanced non-small-cell lung cancer: an individual
patient data meta-analysis. J Natl Cancer Inst. 99:847–857. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Douple EB, Richmond RC, O’Hara JA and
Coughlin CT: Carboplatin as a potentiator of radiation therapy.
Cancer Treat Rev. 12:111–124. 1985. View Article : Google Scholar
|
|
10.
|
Edelstein MP, Wolfe LA III and Duch DS:
Potentiation of radiation therapy by vinorelbine (Navelbine) in
non-small cell lung cancer. Semin Oncol. 23:41–47. 1996.PubMed/NCBI
|
|
11.
|
Riedel RF, Andrews C, Garst J, et al: A
phase II trial of carboplatin/vinorelbine with pegfilgrastim
support for the treatment of patients with advanced non-small cell
lung cancer. J Thorac Oncol. 2:520–525. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Bretti S, Manzin E, Celano A, Ritorto G,
Loddo C and Berruti A: Low-dose carboplatin (AUC4.5) combined with
vinorelbine in the treatment of advanced non-small cell lung
cancer: A single institution phase II study. Oncol Rep. 8:381–385.
2001.PubMed/NCBI
|
|
13.
|
Hoffman PC, Cohen EE, Masters GA, et al:
Carboplatin plus vinorelbine with concomitant radiation therapy in
advanced non-small cell lung cancer: a phase I study. Lung Cancer.
38:65–71. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Edelman MJ, Suntharalingam M, Burrows W,
et al: Phase I/II trial of hyperfractionated radiation and
chemotherapy followed by surgery in stage III lung cancer. Ann
Thorac Surg. 86:903–911. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Masters GA, Hahn EA, Shevrin DH and Kies
MS: Phase I/II trial of vinorelbine and divided-dose carboplatin in
advanced non-small cell lung cancer. Lung Cancer. 39:221–226. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Zatloukal P, Petruzelka L, Zemanova M, et
al: Concurrent versus sequential chemoradiotherapy with cisplatin
and vinorelbine in locally advanced non-small cell lung cancer: a
randomized study. Lung Cancer. 46:87–98. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Segawa Y, Kiura K, Takigawa N, et al:
Phase III trial comparing docetaxel and cisplatin combination
chemotherapy with mitomycin, vindesin, and cisplatin combination
chemotherapy with concurrent thoracic radiotherapy in locally
advanced non-small-cell lung cancer: OLCSG 0007. J Clin Oncol.
28:3299–3306. 2010. View Article : Google Scholar
|
|
18.
|
Hanna N, Neubauer M, Yiannoutsos C, et al:
Phase III study of cisplatin, etoposide, and concurrent chest
radiation with or without consolidation docetaxel in patients with
inoperable stage III non-small-cell lung cancer: the Hoosier
Oncology Group and U.S. Oncology. J Clin Oncol. 26:5755–5760. 2008.
View Article : Google Scholar
|
|
19.
|
Kelly K, Chansky K, Gaspar LE, et al:
Phase III trial of maintenance gefitinib or placebo after
concurrent chemoradiotherapy and docetaxel con4=8solidation in
inoperable stage III non-small-cell lung cancer: SWOG S0023. J Clin
Oncol. 26:2450–2456. 2008.
|
|
20.
|
Spigel DR, Hainsworth JD, Yardley DA, et
al: Tracheoesophageal fistula formation in patients with lung
cancer treated with chemoradiation and bevacizumab. J Clin Oncol.
28:43–48. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Furuse K, Fukuoka M, Kawahara M, et al:
Phase III study of concurrent versus sequential thoracic
radiotherapy in combination with mitomycin, vindesin, and cisplatin
in unresectable stage III non-small-cell lung cancer. J Clin Oncol.
17:2692–2699. 1999.
|
|
22.
|
Haasbeek CJ, Slotman BJ and Senan S:
Radiotherapy for lung cancer: clinical impact of recent technical
advances. Lung Cancer. 64:1–8. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Gould MK, Kuschner WG, Rydzak CE, et al:
Test performance of positron emission tomography and computed
tomography for mediastinal staging in patients with non-small-cell
lung cancer. Ann Intern Med. 139:879–892. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Birim O, Kappetein AP, Stijnen T and
Bogers AJ: Meta-analysis of positron emission tomographic and
computed tomographic imaging in detecting mediastinal lymph node
metastases in non-small cell lung cancer. Ann Thorac Surg.
79:375–381. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Detterbeck FC, Jantz MA, Wallace M,
Vansteenkiste J and Silvestri GA: American College of Chest
Physicians. Invasive mediastinal staging of lung cancer: AACP
evidence-based clinical practice guidelines (2nd Edition). Chest.
132:S202–S220. 2007. View Article : Google Scholar : PubMed/NCBI
|
